ATYR
aTyr Pharma
ATYR
ATYR
37 hedge funds and large institutions have $72.8M invested in aTyr Pharma in 2023 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 7 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
3% more funds holding
Funds holding: 36 → 37 (+1)
1.94% more ownership
Funds ownership: 63.27% → 65.21% (+1.9%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
37
Holding in Top 10
1
Calls
$22K
Puts
$7K
Top Buyers
| 1 | +$10.4M | |
| 2 | +$10.1M | |
| 3 | +$7.61M | |
| 4 |
SB
Samsara BioCapital
Palo Alto,
California
|
+$3.67M |
| 5 |
TM
Tikvah Management
Charlotte,
North Carolina
|
+$2.33M |
Top Sellers
| 1 | -$2.57M | |
| 2 | -$1.64M | |
| 3 | -$938K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$272K |
| 5 |
Millennium Management
New York
|
-$149K |